Bicara Therapeutics Vs. Summit Midstream Industry Stock Comparison

Sell

43

BCAX
Bicara Therapeutics

Last Price:

$14.19

Seasonality Move:

--

Sell

37

SMC
Summit Midstream

Last Price:

$29.00

Seasonality Move:

5.89%

Sell

43

Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

The current Bicara Therapeutics [BCAX] share price is $12.97. The Score for BCAX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
BCAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

37

Summit Midstream (SMC) is a Sell

Is Summit Midstream a Buy, Sell or Hold?

The current Summit Midstream [SMC] share price is $28.34. The Score for SMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
SMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

The Bicara Therapeutics share price today is $12.97

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCAX is experiencing slight selling pressure.

SMC Stock Price Chart

What is Summit Midstream's stock price today?

The Summit Midstream share price today is $28.34

The current trend is relatively stagnant and SMC is experiencing slight buying pressure.

BCAX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.16	Buy
Relative Strength Index (14 RSI):	48.44	Sell
Chaikin Money Flow:	-291117	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(10.82 - 14.58)	Buy
Bollinger Bands (100):	(11.54 - 15.96)	Sell

SMC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.27	Sell
Relative Strength Index (14 RSI):	44.53	Sell
Chaikin Money Flow:	7541	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(27.11 - 29.13)	Buy
Bollinger Bands (100):	(30.8 - 42.12)	Sell

BCAX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	13.53	Sell
20-day SMA:	13.38	Sell
50-day SMA:	13.04	Sell
200-day SMA:	0	Buy
8-day EMA:	13.3	Sell
20-day EMA:	13.3	Sell
50-day EMA:	13.24	Sell
200-day EMA:	11.69	Buy

SMC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	27.68	Buy
20-day SMA:	28.17	Buy
50-day SMA:	32.81	Sell
200-day SMA:	36.3	Sell
8-day EMA:	28	Buy
20-day EMA:	28.78	Sell
50-day EMA:	31.87	Sell
200-day EMA:	34.26	Sell

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.00 per share, and a decrease next year of $0.52 per share.

Summit Midstream Earnings Growth & SMC Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bicara Therapeutics Technical Analysis

	Apr 28	Apr 29	Apr 30	May 1	May 2	May 5	May 6	May 7	May 8	May 9
	Apr				May
	28	29	30	01	02	05	06	07	08	09
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Summit Midstream Technical Analysis

	Apr 28	Apr 29	Apr 30	May 1	May 2	May 5	May 6	May 7	May 8	May 9
	Apr				May
	28	29	30	01	02	05	06	07	08	09
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):